U.S. to pay $1.5B for Moderna's COVID-19 vaccine

By The Science Advisory Board staff writers

August 12, 2020 -- The U.S. government awarded a maximum $1.525 billion contract to Moderna to secure 100 million doses of its messenger RNA (mRNA) COVID-19 vaccine.

The government signed the deal for Moderna's mRNA-1273 vaccine through its Operation Warp Speed project. The deal includes an option to buy an additional 400 million doses of the vaccine in the future. Americans will receive the vaccine at no cost for the vaccine itself.

This new contract covers the manufacturing and delivery of 100 million doses, including incentive payments for their timely delivery. These funds, along with the previous award of up to $955 million from the U.S. Biomedical Advanced Research and Development Authority for the development of the vaccine, totals up to $2.48 billion.

In July, Moderna announced that its vaccine was safe and triggered immune responses in healthy adults.

Amazon powers Moderna's digital biotech platform
Amazon Web Services is providing cloud, analytics, and machine-learning services to Moderna for its messenger RNA platform and manufacturing facility.
J&J to provide U.S. with 100M doses of COVID-19 vaccine
Johnson & Johnson will manufacture and deliver 100 million doses of its SARS-CoV-2 investigational vaccine to the U.S. government once it receives...
Animal study turns in positive results for Moderna-NIH COVID-19 vaccine
Moderna's COVID-19 vaccine candidate, messenger RNA (mRNA)-1273, has been shown to induce immune responses and control upper and lower respiratory tract...
Moderna begins phase III testing of COVID-19 vaccine
Moderna has begun a phase III clinical trial evaluating its messenger RNA (mRNA)-1273 COVID-19 vaccine candidate. The trial is expected to enroll approximately...
Moderna reports positive results in COVID-19 vaccine trial
Moderna is reporting positive results with a COVID-19 vaccine candidate it is developing. The candidate, messenger RNA (mRNA)-1273, was safe and triggered...

Copyright © 2020 scienceboard.net

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter